NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

Buyer: NHS England

Deadline

Not available — this notice may describe a possible future opportunity.

Region

Not specified

Value

—

Type

Award,contract

SME fit

—

Duration

—

Description

NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Awarded to

ALFASIGMA UK LIMITED AVENTIS PHARMA LIMITED t-a Sanofi BIOSIMILAR COLLABORATIONS IRELAND LIMITED CELLTRION HEALTHCARE UK LIMITED

Quick actions

View original notice

Key details

CPV category: —
Procurement method: Open procedure
Published: 10 Jul 2026 10:46
VCSE suitable: —

Reference

OCID: ocds-h6vhtk-051a9d
Notice ID: C414011
In our database since: 17 Aug 2026